In a study looking specifically at HCV infection rates in HIV-positive gay men, the researchers found the proportion of HIV positive gay men with HCV increased slightly from 2004 to 2011, and that current treatment rates were unlikely to reduce HCV transmission over time.
19 May 2016 | Eurekalert Inf Dis
Interview with Magdalena Harris, Lecturer at the London School of Hygiene and Tropical Medicine, on how she came to work with viral hepatitis, how the field has been changing, and what new research is called for.
17 May 2016 | BioMed Central blogs
The UNGASS was certainly not a success for the defenders of the status quo. The consensus on punitive prohibition has been well and truly ripped apart at the seams. This UNGASS demonstrates the impact civil society pressure can achieve. The drug policy reform movement will continue to grow into a formidable global social movement towards 2019. The collective demand for change will grow ever louder leading to sustainable and seismic break-throughs at national, regional and ultimately UN levels.
04 May 2016 | International Drug Policy Consortium
Health Minister Terry Lake on Thursday announced a $5-million study that will look at how to reduce the spread of hepatitis C among intravenous drug users, sex workers and men who have sex with men. It will concentrate on people who have already taken medication that clears them of the hepatitis C virus, but who could be reinfected if they have blood-to-blood contact with another person. They will be encouraged to prevent that by using condoms, not sharing needles and taking part in support programs through Vancouver Coastal Health, one of the five organizations involved in the program.
22 April 2016 | Vancouver Sun
Interview with Eberhard Schatz, one of the two coordinators of Correlation, the European social inclusion and health network.
14 April 2016 | BioMed Central blogs
Experts had estimated incidence at around 10,000. However, the report puts the number suffering from chronic Hepatitis C at over 80,000. Many of those infected are unaware of the fact and could pass it on to others.
01 April 2016 | Radio Prague
"PrEP is indeed a step forward in HIV-prevention, but like anything new and shiny, it’s having systemic teething issues in our community. This article was not written to lecture those who have a passion for barebacking on or off PrEP (that is entirely your decision and you should feel empowered in whatever you do) merely I needed to voice concerns to those on the fence, to those who are unsure of whether to dive in to a condom-free world, to those who may or may not be on PrEP and aren’t willing to abandon condoms just yet."
29 March 2016 | Same Same
Médecins du Monde (MdM) and Treatment Action Group (TAG) are pleased to announce the launch of mapCrowd (www.mapCrowd.org), an innovative online resource and data collection platform for gathering and sharing hepatitis C information.
09 February 2016 | Treatment Action Group
The number of reported newly acquired hepatitis C virus (HCV) infection among hemodialysis patients is growing, the CDC said. In an announcement posted on its website late Wednesday, the CDC said it was contacted about 36 cases of acute HCV infections at 19 different clinics, and that in nine of those clinics, HCV transmission was found to occur between patients.
29 January 2016 | MedPage Today HIV/AIDS
Half of known injecting drug users are at risk of contracting Hepatitis C, Public Health Wales has warned. It said so-called legal highs had been "a real game changer" and the health risk was becoming a "substantial" problem.
03 January 2016 | BBC News